483
Guenther Koehne, M.D.FDA 483 - Guenther Koehne, M.D. - January 10, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Guenther Koehne, M.D. at Miami Cancer Institute revealed significant deviations in the conduct of a clinical investigation. The firm failed to follow the investigational plan, specifically by not reporting serious adverse events for multiple subjects and enrolling more subjects than permitted by the study protocol. These findings indicate serious non-compliance with clinical trial regulations.
Open in Dashboard
ID · 3e472d7a-a834-48b4-ab6d-b1540efccf33